Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard Ca Murray Insider Profile
4 Followers
Richard Ca Murray, EVP & CSO at PDL BioPharma, holds 70.16K shares in PDL BioPharma (Ticker: PDLI), holds 1.00 shares in Jounce Therapeutics (Ticker: JNCE). Most recently, Richard Ca Murray ― shares of PDL BioPharma on ― for an estimated value of ―.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+29.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Richard Ca Murray does not currently own shares as a corporate insider.
A breakdown of Richard Ca Murray's holdings
Insider Roles
Richard Ca Murray does not currently hold a role as a corporate insider.
Roles that Richard Ca Murray holds in companies
Most Profitable Insider Trade
Stock:
Jounce Therapeutics
(JNCE)
(JNCE)
Rating:Informative Sell
Date:Jan 11, 2022 - Jan 11, 2023
Return:+80.90%
The most profitable trade made by Richard Ca Murray
Richard Ca Murray's Trading History
PDL BioPharma
―
―
―
$173.29K
Jounce Therapeutics
May 04, 2023
―
Uninformative Sell
―
$1.88
List of latest transactions for each holding click on a transaction to see Richard Ca Murray's performance on stock
You May Also Like
Richard Ca Murray insider profile FAQ
What is the percentage of profitable transactions made by Richard Ca Murray?
The percentage of profitable transactions made by Richard Ca Murray is 100%.
What is the average return per transaction made by Richard Ca Murray?
The average return per transaction made by Richard Ca Murray is 29.50%.
What stocks does Richard Ca Murray hold?
Richard Ca Murray holds: PDLI, JNCE stocks.
What was Richard Ca Murray’s latest transaction?
Richard Ca Murray latest transaction was an Uninformative Buy of ―.
What was Richard Ca Murray's most profitable transaction?
Richard Ca Murray’s most profitable transaction was an Informative Sell of JNCE stock on January 11, 2022. The return on the trade was 80.90%.
What is Richard Ca Murray's role in PDL BioPharma?
Richard Ca Murray's role in PDL BioPharma is EVP & CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.